tiprankstipranks
Trending News
More News >
G Medical Innovations Holdings (GMVDF)
OTHER OTC:GMVDF
US Market

G Medical Innovations Holdings (GMVDF) Ratios

Compare
27 Followers

G Medical Innovations Holdings Ratios

GMVDF's free cash flow for Q2 2022 was $―. For the 2022 fiscal year, GMVDF's free cash flow was decreased by $ and operating cash flow was $―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 22Dec 21Dec 20Dec 19
Liquidity Ratios
Current Ratio
0.22----
Quick Ratio
0.19----
Cash Ratio
0.03----
Solvency Ratio
-2.59----
Operating Cash Flow Ratio
-2.03----
Short-Term Operating Cash Flow Coverage
-10.22----
Net Current Asset Value
$ -7.40M----
Leverage Ratios
Debt-to-Assets Ratio
0.43----
Debt-to-Equity Ratio
-0.28----
Debt-to-Capital Ratio
-0.40----
Long-Term Debt-to-Capital Ratio
-0.04----
Financial Leverage Ratio
-0.66----
Debt Service Coverage Ratio
-20.88----
Interest Coverage Ratio
0.00----
Debt to Market Cap
1.16----
Interest Debt Per Share
0.00----
Net Debt to EBITDA
-0.05----
Profitability Margins
Gross Profit Margin
17.74%----
EBIT Margin
-683.42%----
EBITDA Margin
-854.10%----
Operating Profit Margin
-620.14%----
Pretax Profit Margin
-315.43%----
Net Profit Margin
-315.79%----
Continuous Operations Profit Margin
-315.79%----
Net Income Per EBT
100.11%----
EBT Per EBIT
50.86%----
Return on Assets (ROA)
-289.28%----
Return on Equity (ROE)
208.58%----
Return on Capital Employed (ROCE)
639.23%----
Return on Invested Capital (ROIC)
1106.96%----
Return on Tangible Assets
-289.28%----
Earnings Yield
0.00%----
Efficiency Ratios
Receivables Turnover
4.68----
Payables Turnover
0.78----
Inventory Turnover
12.45----
Fixed Asset Turnover
1.67----
Asset Turnover
0.92----
Working Capital Turnover Ratio
-1.29----
Cash Conversion Cycle
-360.03----
Days of Sales Outstanding
77.95----
Days of Inventory Outstanding
29.31----
Days of Payables Outstanding
467.29----
Operating Cycle
107.27----
Cash Flow Ratios
Operating Cash Flow Per Share
0.00----
Free Cash Flow Per Share
0.00----
CapEx Per Share
0.00----
Free Cash Flow to Operating Cash Flow
1.11----
Dividend Paid and CapEx Coverage Ratio
-8.71----
Capital Expenditure Coverage Ratio
-8.71----
Operating Cash Flow Coverage Ratio
-8.83----
Operating Cash Flow to Sales Ratio
-4.18----
Free Cash Flow Yield
-1143.71%----
Valuation Ratios
Price-to-Earnings (P/E) Ratio
0.00----
Price-to-Sales (P/S) Ratio
0.41----
Price-to-Book (P/B) Ratio
0.00----
Price-to-Free Cash Flow (P/FCF) Ratio
-0.09----
Price-to-Operating Cash Flow Ratio
0.00----
Price-to-Earnings Growth (PEG) Ratio
0.00----
Price-to-Fair Value
0.00----
Enterprise Value Multiple
-0.10----
Enterprise Value
3.60M----
EV to EBITDA
-0.10----
EV to Sales
0.81----
EV to Free Cash Flow
-0.17----
EV to Operating Cash Flow
-0.19----
Tangible Book Value Per Share
0.00----
Shareholders’ Equity Per Share
0.00----
Tax and Other Ratios
Effective Tax Rate
>-0.01----
Revenue Per Share
0.00----
Net Income Per Share
0.00----
Tax Burden
1.00----
Interest Burden
0.46----
Research & Development to Revenue
0.52----
SG&A to Revenue
5.62----
Stock-Based Compensation to Revenue
2.83----
Income Quality
0.74----
Currency in USD